Evidence map›Paper›PMID 30645140›Full record

ArticleAmerican journal of respiratory and critical care medicine2019

Reply to te Brake

Gustavo E Velásquez, Meredith B Brooks, Julia M Coit, Epifanio Sánchez Garavito, Roger I Calderón, Judith Jiménez, Karen Tintaya, Charles A Peloquin, Elna Osso, Leonid Lecca and 2 more

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in American journal of respiratory and critical care medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Gustavo E Velásquez1 Brigham and Women's Hospital Boston, Massachusetts.ORCID 0000-0003-1438-0692
Meredith B Brooks2 Harvard Medical School Boston, Massachusetts.
Julia M Coit2 Harvard Medical School Boston, Massachusetts.
Epifanio Sánchez Garavito3 Hospital Nacional Sergio Bernales Lima, Peru.
Roger I Calderón4 Partners In Health/Socios En Salud Sucursal Peru Lima, Peru.
Judith Jiménez4 Partners In Health/Socios En Salud Sucursal Peru Lima, Peru.
Karen Tintaya4 Partners In Health/Socios En Salud Sucursal Peru Lima, Peru.
Charles A Peloquin5 University of Florida Gainesville, Florida.
Elna Osso2 Harvard Medical School Boston, Massachusetts.
Leonid Lecca2 Harvard Medical School Boston, Massachusetts.
Geraint R Davies6 University of Liverpool Liverpool, United Kingdom and.
Carole D Mitnick1 Brigham and Women's Hospital Boston, Massachusetts.

Funding

Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/UM1AI068636 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Joseph J Eron, RAJESH T GANDHI · 2011 to 2026
$1073.1M
Randomized Trial of High-Dose Rifampin in Patients with New Smear-Positive TBU01AI091429 · NIAID · HARVARD MEDICAL SCHOOL · PI DAVIES, GERAINT, MITNICK, CAROLE D. · 2011 to 2013
$8.5M
NIAID NIH HHS L30 AI120170NIAID NIH HHS U01 AI091429NIAID NIH HHS UM1 AI068636
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

RifampinTuberculosis, PulmonaryAntitubercular AgentsHumansAntitubercular AgentsRifampin

Identifiers

PMID30645140
PMCPMC6515881

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.